Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 3, 2010, Pages 214-219

  Antón, Andrés ^a   López Iglesias, Ana Alicia ^b   Tórtola, Teresa ^b   Ruiz Camps, Isabel ^b   Abrisqueta, Pau ^b   Llopart, Lluís ^b   Marcos, María Ángeles ^a   Martínez, Miguel Julián ^a   Tudó, Griselda ^a   Bosch, Francesc ^b   Pahissa, Albert ^b   de Anta, María Teresa Jiménez ^a   Pumarola, Tomàs ^a  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

H275Y; Oseltamivir; Pandemic influenza; Resistance; Viral load

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

AGED; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; GENETIC SCREENING; GENOTYPE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; LYMPHADENOPATHY; MALE; MUTATIONAL ANALYSIS; NASOPHARYNGEAL ASPIRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; VIRUS DETECTION; VIRUS LOAD; VIRUS RESISTANCE; VIRUS SHEDDING; VIRUS STRAIN; WILD TYPE;

AGED; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; NASOPHARYNX; OSELTAMIVIR; RNA, VIRAL; SELECTION, GENETIC; VIRAL LOAD; VIRUS SHEDDING;

EID: 77957904374     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.08.003     Document Type: Article

References (22)

1. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 1990, 215:403-410.
2. Campanini G., Piralla A., Rovida F., Puzelli S., Facchini M., Locatelli F., Minoli L., Percivalle E., Donatelli I., Baldanti F. First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection. J. Clin. Virol. 2010, 48:220-222. Surveillance Group for New Influenza A/H1N1v Investigation in Italy.
3. Deyde V.M., Sheu T.G., Trujillo A.A., Okomo-Adhiambo M., Garten R., Klimov A.I., Gubareva L.V. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 2010, 54:1102-1110.
4. Dharan N.J., Gubareva L.V., Meyer J.J., Okomo-Adhiambo M., McClinton R.C., Marshall S.A., St George K., Epperson S., Brammer L., Klimov A.I., Bresee J.S., Fry A.M. Oseltamivir-Resistance Working Group. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009, 301:1034-1041.
5. Duchamp M.B., Casalegno J.S., Gillet Y., Frobert E., Bernard E., Escuret V., Billaud G., Valette M., Javouhey E., Lina B., Floret D., Morfin F. Pandemic A(H1N1)2009 influenza virus detection by real-time RT-PCR: is viral quantification useful?. Clin. Microbiol. Infect. 2010, 16:317-321.
6. European Centre for Disease Prevention and Control, ECDC Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. Wkly. Epidemiol. Rec. 2009, 84:453-459.
7. Gooskens J., Jonges M., Claas E.C., Meijer A., Kroes A.C. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J. Infect. Dis. 2009, 99:1435-1441.
8. Gubareva L.V., Fry A.M. Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses. J. Infect. Dis. 2010, 201:656-658.
9. Gulland A. First cases of spread of oseltamivir-resistant swine flu between patients are reported in Wales. BMJ 2009, 23:b4975.
10. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
11. Liu C.M., Driebe E.M., Schupp J., Kelley E., Nguyen J.T., McSharry J.J., Weng Q., Engelthaler D.M., Keim P.S. Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis. J. Virol. Methods. 2010, 163:109-115.
12. McKimm-Breschkin J., Trivedi T., Hampson A., Hay A., Klimov A., Tashiro M., Hayden F., Zambon M. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother. 2003, 47:2264-2272.
13. Meijer A., Lackenby A., Hungnes O., Lina B., van-der-Werf S., Schweiger B., Opp M., Paget J., van-de-Kassteele J., Hay A., Zambon M. European Influenza Surveillance Scheme. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg. Infect Dis. 2009, 15:552-560.
14. Palmer S., Kearney M., Maldarelli F., Halvas E.K., Bixby C.J., Bazmi H., Rock D., Falloon J., Davey R.T., Dewar R.L., Metcalf J.A., Hammer S., Mellors J.W., Coffin J.M. Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J. Clin. Microbiol. 2005, 43:406-413.
15. Rozen S., Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics methods and protocols: methods in molecular biology 2000, 365-386. Humana Press, Totowa, NJ. S. S Krawetz, S. Misener (Eds.).
16. Suwannakarn K., Payungporn S., Chieochansin T., Samransamruajkit R., Amonsin A., Songserm T., Chaisingh A., Chamnanpood P., Chutinimitkul S., Theamboonlers A., Poovorawan Y. Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J. Virol. Methods 2008, 152:25-31.
17. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
18. van der Vries E., Jonges M., Herfst S., Maaskant J., Van der Linden A., Guldemeester J., Aron G.I., Bestebroer T.M., Koopmans M., Meijer A., Fouchier R.A., Osterhaus A.D., Boucher C.A., Schutten M. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J. Clin. Virol. 2010, 47:34-37.
19. World Health Organization WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection Available at:, Accessed: January 12, 2005. http://www.who.int/csr/disease/avian_influenza/guidelines/humanspecimens/en/.
20. World Health Organization WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses Available at:, Accessed: August 20, 2009. http://www.who.int/csr/resources/publications/swineflu/h1n1_use_antivirals_20090820/en/index.html.
21. World Health Organization CDC Protocol of Realtime RTPCR for influenza A (H1N1) Available at:, Accessed: October 6, 2009. http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/.
22. World Health Organization Weekly update on oseltamivir resistance to pandemic influenza A (H1N1) 2009 viruses Available at:, Accessed: July 14, 2010. http://www.who.int/entity/csr/disease/swineflu/oseltamivirresistant20100716.pdf.